Skip to main content

Z Zhang

First name:
Z
Last name:
Zhang
Zhang, Z. ., Zhang, Y. ., Chen, G. ., Hong, S. ., Yang, Y. ., Fang, W. ., … Zhang, L. . (2018). Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis. The Oncologist. https://doi.org/10.1634/theoncologist.2017-0378 (Original work published 2018)
Liu, P. ., Chen, J. ., Zhang, Z. ., Xie, Z. ., Du, X. ., & Gu, Z. . (2018). Bio-inspired robust non-iridescent structural color with self-adhesive amorphous colloidal particle arrays. Nanoscale. https://doi.org/10.1039/c7nr08056e (Original work published 2018)
Zhu, G. ., Wang, S. ., Huang, Z. ., Zhang, S. ., Liao, Q. ., Zhang, C. ., … Huang, S. . (2018). Rewiring of the Fruit Metabolome in Tomato Breeding. Cell, 172(1-2), 249-261.e12. https://doi.org/10.1016/j.cell.2017.12.019 (Original work published 2018)
Bradley, L. ., Fuqua, J. ., Richardson, A. ., Turchan-Cholewo, J. ., Ai, Y. ., Kelps, K. ., … Gerhardt, G. . (2010). Dopamine neuron stimulating actions of a GDNF propeptide. PloS One, 5(3), e9752. https://doi.org/10.1371/journal.pone.0009752 (Original work published 2010)
Hardy, P. ., Keeley, D. ., Schorn, G. ., Forman, E. ., Ai, Y. ., Venugopalan, R. ., … Bradley, L. . (2013). Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine. Journal of Neuroscience Methods, 219(1), 169-75. https://doi.org/10.1016/j.jneumeth.2013.07.013 (Original work published 2013)
Zhang, S. ., Zhang, M. ., Jing, Y. ., Yin, X. ., Ma, P. ., Zhang, Z. ., … Zhuang, G. . (2018). Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nature Communications, 9(1), 215. https://doi.org/10.1038/s41467-017-02693-9 (Original work published 2018)
Neugebauer, N. ., Zhang, Z. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2006). Effect of a novel nicotinic receptor antagonist, N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Psychopharmacology, 184(3-4), 426-34. https://doi.org/10.1007/s00213-005-0163-8
Rahman, S. ., Neugebauer, N. ., Zhang, Z. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2007). The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology, 52(3), 755-63. https://doi.org/10.1016/j.neuropharm.2006.09.012
Rahman, S. ., Zhang, Z. ., Papke, R. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2008). Region-specific effects of N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo. British Journal of Pharmacology, 153(4), 792-804. https://doi.org/10.1038/sj.bjp.0707612
Dwoskin, L. ., Wooters, T. ., Sumithran, S. ., Siripurapu, K. ., Joyce, B. ., Lockman, P. ., … Bardo, M. . (2008). N,N’-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal of Pharmacology and Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630